Freire Diana Mendes, Gutierrez Claude, Garza-Garcia Acely, Grabowska Anna D, Sala Ambre J, Ariyachaokun Kanchiyaphat, Panikova Terezie, Beckham Katherine S H, Colom André, Pogenberg Vivian, Cianci Michele, Tuukkanen Anne, Boudehen Yves-Marie, Peixoto Antonio, Botella Laure, Svergun Dmitri I, Schnappinger Dirk, Schneider Thomas R, Genevaux Pierre, de Carvalho Luiz Pedro Sorio, Wilmanns Matthias, Parret Annabel H A, Neyrolles Olivier
European Molecular Biology Laboratory, Hamburg Unit, Notkestraße 85, 22607 Hamburg, Germany.
Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 205 route de Narbonne, 31400 Toulouse, France.
Mol Cell. 2019 Mar 21;73(6):1282-1291.e8. doi: 10.1016/j.molcel.2019.01.028. Epub 2019 Feb 18.
Toxin-antitoxin (TA) systems regulate fundamental cellular processes in bacteria and represent potential therapeutic targets. We report a new RES-Xre TA system in multiple human pathogens, including Mycobacterium tuberculosis. The toxin, MbcT, is bactericidal unless neutralized by its antitoxin MbcA. To investigate the mechanism, we solved the 1.8 Å-resolution crystal structure of the MbcTA complex. We found that MbcT resembles secreted NAD-dependent bacterial exotoxins, such as diphtheria toxin. Indeed, MbcT catalyzes NAD degradation in vitro and in vivo. Unexpectedly, the reaction is stimulated by inorganic phosphate, and our data reveal that MbcT is a NAD phosphorylase. In the absence of MbcA, MbcT triggers rapid M. tuberculosis cell death, which reduces mycobacterial survival in macrophages and prolongs the survival of infected mice. Our study expands the molecular activities employed by bacterial TA modules and uncovers a new class of enzymes that could be exploited to treat tuberculosis and other infectious diseases.
毒素-抗毒素(TA)系统调控细菌的基本细胞过程,是潜在的治疗靶点。我们报道了一种存在于包括结核分枝杆菌在内的多种人类病原体中的新型RES-Xre TA系统。毒素MbcT具有杀菌作用,除非被其抗毒素MbcA中和。为了研究其作用机制,我们解析了MbcTA复合物分辨率为1.8 Å的晶体结构。我们发现MbcT类似于分泌型NAD依赖性细菌外毒素,如白喉毒素。实际上,MbcT在体外和体内均催化NAD降解。出乎意料的是,该反应受到无机磷酸盐的刺激,并且我们的数据表明MbcT是一种NAD磷酸化酶。在没有MbcA的情况下,MbcT会引发结核分枝杆菌细胞快速死亡,这会降低分枝杆菌在巨噬细胞中的存活率,并延长感染小鼠的存活时间。我们的研究扩展了细菌TA模块所采用的分子活性,并揭示了一类可用于治疗结核病和其他传染病的新型酶。